- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Cyclin-Dependent Kinase Inhibitor Proteins
Total 11887 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
PrECOG, LLC.PfizerTerminatedRenal Cell CarcinomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Pleural Malignant Mesothelioma | Stage IV Pleural MesotheliomaUnited States
-
RenJi HospitalRecruitingHepatocellular Carcinoma | Liver Cancer | Resistant CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsActive, not recruitingMelanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell Carcinoma | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal NeoplasmUnited States
-
PfizerRecruitingUlcerative ColitisFrance
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Incepta Pharmaceuticals LtdCompletedTofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation StudyAxial SpondyloarthritisBangladesh
-
Albany Research Institute, Inc.CompletedRosacea, ErythematotelangiectaticUnited States
-
University Hospital, LillePfizerTerminated
-
Hoffmann-La RocheActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Hungary, Australia, Taiwan, China, Denmark, Italy, Spain, Turkey, Japan, France, Korea, Republic of, Germany, Poland, Thailand, Egypt, Russian Federation, Austria, Ukraine, United Kingdom, Romania, Kazakhstan, Bosnia... and more
-
Northwestern UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCActive, not recruitingStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedCarcinoid Tumor | Neuroendocrine Neoplasm | Metastatic Carcinoid TumorUnited States
-
Jinnah HospitalCompletedAlopecia Areata | Alopecia Totalis | Alopecia UniversalisPakistan
-
PfizerCompleted
-
Fudan UniversityActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Steroid Refractory Graft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
PfizerRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Autoimmune Hemolytic Anemia | Warm Antibody Autoimmune Hemolytic Anemia | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSoft Tissue Sarcoma | Osteosarcoma | Ewing Sarcoma | Malignant Glioma | Ependymoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Children's Hospital Medical Center, CincinnatiPfizerCompletedSystemic Lupus Erythematosus | Cutaneous LupusUnited States
-
Zhejiang Provincial People's HospitalRecruitingRheumatoid Arthritis | Treatment Compliance | AbataceptChina
-
PfizerRecruitingUlcerative ColitisUnited States, Israel, Poland, Canada, Japan, Belgium, Spain, Hungary, Finland, France, Australia, United Kingdom, Germany, Italy, Sweden, Netherlands, Slovakia
-
PfizerCompletedArthritis, RheumatoidFrance
-
PfizerCompletedPsoriatic ArthritisChina
-
Sahar Mohammed GadNot yet recruitingChronic Myeloid Leukemia in Remission
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
-
Emory UniversityTerminatedRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
PfizerTerminatedPlaque PsoriasisUnited States, Canada
-
PfizerRecruitingActive Psoriatic Arthritis | Active Ankylosing Spondylitis | Active Moderate to Severe Rheumatoid ArthritisKorea, Republic of
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Yanfeng HouRecruitingRheumatoid Arthritis | TherapyChina
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, Australia, United Kingdom, Denmark, France, Italy, Germany
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMinimal Residual Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionUnited States
-
Emory UniversityEisai Inc.TerminatedDifferentiated Thyroid Gland Carcinoma | Thyroid Gland Follicular Carcinoma | Thyroid Gland Papillary CarcinomaUnited States
-
University of Texas Southwestern Medical CenterPfizerRecruiting
-
National Cancer Institute (NCI)RecruitingChronic GVHDUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Milton S. Hershey Medical Center; Stanford University and other collaboratorsActive, not recruitingLymphoma | Leukemia | Solid Tumor | Central Nervous System TumorUnited States, Canada
-
PfizerActive, not recruiting
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Sun Yat-sen UniversityNot yet recruitingEndometrial Cancer | Endometrial AdenocarcinomaChina
-
Hannover Medical SchoolCompletedHead and Neck Squamous Cell CarcinomaGermany
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySuzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingBiliary Tract Cancer | Gemox ChemotherapyChina
-
Peking University Cancer Hospital & InstituteNot yet recruitingCollecting Duct CarcinomaChina